Peripheral Blood Mononuclear Cells

Since 2007, CellMade™ has provided functionally qualified Peripheral Blood Mononuclear Cells (PBMCs) engineered as assay-ready reagents for pharmaceutical Quality Control and drug safety testing. Fully compliant with Ph. Eur. 2.6.30 and international bio-ethical standards, these cells are available in versatile formats ranging from 10M to 100M cells per unit, including specialized 8-donor pools that minimize individual variability and mirror the "average human" immune response for superior sensitivity. Unlike generic primary cells, every lot is MAT-qualified, pre-screened for reliable cytokine secretion (IL-6, IL-1β, TNF-α), and guaranteed at >90% post-thaw viability to ensure high signal-to-noise ratios in pyrogen and safety assays. By offering full traceability, pathogen-free certification, and a mandatory technical onboarding process—encompassing feasibility, validation, and method transfer—CellMade™ acts as a strategic analytical partner, helping laboratories transition from animal-based testing to robust, human-based molecular models.